• This site is intended for: Healthcare Professionals
  • View Patient/Caregiver Site >
  • Important Safety Information
  • Full Prescribing Information Medication Guide & Prescribing Information
    Quillivant XR QuilliChew ER DYANAVEL XR
Tris Pharma Logo
  • About ADHD
  • LiquiXR Technology
  • Tris ADHD Products
    Quillivant XR QuilliChew ER DYANAVEL XR
  • Resources
  • Request More Info
  • Home
  • About ADHD
  • LiquiXR Technology
  • Tris ADHD Products
    • Quillivant XR
      • About Quillivant XR
      • Efficacy
      • Safety Data
      • PK Data
      • Dosing
      • Patient Profiles
    • QuilliChew ER
      • About QuilliChew ER
      • Efficacy
      • Safety Data
      • PK Data
      • Dosing
      • Patient Profiles
    • DYANAVEL XR
      • About DYANAVEL XR
      • Efficacy
      • Safety Data
      • PK Data
      • Dosing
      • Patient Profiles
  • Resources
Request More Info

Site map

  • Home
  • About ADHD
  • LiquiXR Technology
  • Tris ADHD Products
  • About Quillivant XR
  • Efficacy
  • Safety Data
  • PK Data
  • Dosing
  • Patient Profiles
  • About QuilliChew ER
  • Efficacy
  • Safety Data
  • PK Data
  • Dosing
  • Patient Profiles
  • About DYANAVEL XR
  • Efficacy
  • Safety Data
  • PK Data
  • Dosing
  • Patient Profiles
  • Resources
Back to Top
This site is intended for healthcare professionals in the United States, its territories, and Puerto Rico.
Tris Pharma Logo
  • Site Map
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Unsubscribe
Quillivant XR and QuilliChew ER are registered trademarks
of NextWave Pharmaceuticals, Inc.
DYANAVEL and LiquiXR are registered trademarks of Tris Pharma, Inc.
All other trademarks are the property of their respective owners.
© 2021 Tris Pharma, Inc. All rights reserved. DXR.796.PR     11/21
© 2021 Tris Pharma, Inc. All rights reserved. DXR.796.PR     11/21
  • Tris ADHD Facebook Logo Footer
  • Tris ADHD LinkedIn Logo Footer

You are about to leave this site

You are about to leave TrisADHDhcp.com and enter a website operated by a third party. Would you like to continue?

YesNo

Now Available

For patients 6 years and older with Attention Deficit Hyperactivity Disorder

Once-daily
DYANAVEL® XR (amphetamine)
tablet

Warning: Abuse and Dependence

CNS stimulants, including DYANAVEL XR, other amphetamine-containing products, and methylphenidate, have a high potential for abuse and dependence. Assess the risk of abuse prior to prescribing and monitor for signs of abuse and dependence while on therapy.

Please see additional Important Safety Information below.

Warning: Abuse and Dependence

CNS stimulants, including DYANAVEL XR, other amphetamine-containing products, and methylphenidate, have a high potential for abuse and dependence. Assess the risk of abuse prior to prescribing and monitor for signs of abuse and dependence while on therapy.

Please see additional Important Safety Information below.

Learn More
Tris tablet bottle image
Tris Medical logo

2031 U.S. 130, Monmouth Junction, NJ 08852

DYANAVEL is a registered trademark of Tris Pharma, Inc.

© 2022 Tris Pharma, Inc. All rights reserved. DXR.1295.PR     07/22